| Name | BDP8900 |
|---|
| Description | BDP8900 (BDP-8900) is a highly potent and selective Myotonic dystrophy-related Cdc42-binding kinase MRCK inhibitor with IC50 of 43 nM (MRCKβ), >100-fold selectivity over related ROCK1 or ROCK2; shows similar activity against MRCKα and MRCKβ; displays consistent antiproliferative effects with greatest activity in hematologic cancer cells. |
|---|---|
| References | References 1. Unbekandt M, et al. Cancer Res. 2018 Apr 15;78(8):2096-2114. View Related Products by Target ROCK |
| Molecular Formula | C19H23N5S |
|---|---|
| Molecular Weight | 353.488 |